VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Growth Inhibitor
Preclinical
Small molecule
S
Second Affiliated Hospital, School of Medicine, Zhejiang University
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Bleeding
1 trial
Life-2023-02 Esophagogastric Variceal Bleeding
Recruiting
·
S
Second Affiliated Hospital, School of Medicine, Zhejiang University
·
N/A
·
NCT06011980
·
33 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Growth Inhibitor. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Growth Inhibitor compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Growth Inhibitor. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Second Affiliated Hospital, School of Medicine, Zhejiang University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
S
Second Affiliated Hospital, School of Medicine, Zhejiang University
Related News